Andrés Morales la Madrid
Investigador colaborador
Research group
Medicine Degree (2002) by the Universidad Peruana Cayetano Heredia (Peru). Specialty in Pediatrics (2007) from Vall Hebron Hospital (Spain). Sub Specialty in Oncology, Hematology and Stem Cell Transplantation in Pediatrics (2012) from the University of Chicago (USA). Sub Specialty in Pediatric Neuro Oncology (2013) from Harvard University (2013). Master in Hospital Management and Health Resources (2018) from the University of Barcelona (Spain).
In 2018, he was appointed Clinical Director of the Oncology Area of the SJD Barcelona Children Hospital, Spain.
He leads a clinical research project in immunotherapy for the diffuse intrinsic pontine glioma (DIPG).
Professional network profiles
Related websites
SJD Barcelona Children Hospital Last Publications
- Perganti F, Huybrechts I, Balduzzi AC, Barr R, Biondi A, Bladé AL, Muñoz Bravo E, Damasco E, Katsagoni CN, Kattamis A, Lassaletta A, Llopis Lera M, Llort A, Blanco Lopez J, Perez Martinez A, Massimino M, Morales-La Madrid A, Moreno L, Muñoz Alonso A, Nicolas G, Preziati G, Rizzari S, Della Valle S, Marquez Vega C, Walters M, Kozlakidis Z and Ladas EJ Southern European Prospective Investigation Into Childhood Cancer and Nutrition (EPICkids): Study design and protocol. PLoS One . 20(9): .
- Marina Caballero Bellón, Santa-María López V, Marti-Sanchez L, Martorell-Sampol L, Salinas D, Hinojosa J, Becerra MV, Pavon-Mengual M, Morales-La Madrid A, Cruz-Martínez O, Muchart-Lopez J and Salvador-Hernandez H Very early-onset symptomatic CNS haemangioblastoma in Von Hippel-Lindau disease JOURNAL OF MEDICAL GENETICS . 62(6): 409-412.
- Erker C, Mynarek M, Simbozel M, Craig BT, Harrod VL, Cappellano AM, Cohen KJ, Santa-María López V, Morales-La Madrid A, Cacciotti C, Baroni L, Salloum R, Margol AS, Michaiel G, Aguilera D, Mazewski CM, Kline CN, Finlay JL, Abdelbaki MS, Murray JC, Dorris K, Crooks B, Ginn KF, Amayiri N, Tippelt S, Fleischhack G, Tonn S, Gerber NU, Lassaletta A, Hansford JR, Khan S, Gilheeney SW, Hoffman LM, Zapotocky M, Larouche V, Shah S, Ramaswamy V, Gajjar A, Perreault S, Mueller S, Hukin J, Cheng S, Wang ZJ, Matheson K, Bailey S, Bouffet E, Clifford SC, Robinson G, Dufour C, Rutkowski S and Lafay-Cousin L Salvage therapies for first relapse of SHH medulloblastoma in early childhood Neuro-Oncology . : .
Projects
- Project name:
- LATE-AYA: Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach
- Leader
- Andrés Morales La Madrid
- Funding entities:
- European Commission
- Code
- 101214326
- Starting - finishing date:
- 2025 - 2030
- Project name:
- ADVANCED THERAPIES (RICORS-TERAV)
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- RD24/0014/0006
- Starting - finishing date:
- 2025 - 2027
- Project name:
- ICF (Exploratory study on the provision of care for Adolescent and Young Adult (AYA) cancer patients in the Union)
- Leader
- Andrés Morales La Madrid
- Funding entities:
- European Commission
- Code
- 330301961
- Starting - finishing date:
- 2025 - 2026
News
-
The Institut de Recerca Sant Joan de Déu drives the first in-person meeting of the cancer Survivorship Network of Expertise of the JANE2 project
On May 9th, the Institut de Recerca Sant Joan de Déu (IRSJD) brought together the leaders of the Survivorship Network of Expertise, a network framed within the Joint Action on Network of Expertise (JANE2) project, one of the pillars of the European Beating Cancer Plan. During the meeting, key challenges and activities to advance care for cancer survivors in Europe were addressed, and a "working definition" was proposed to help establish an integrative care model for survivors.